SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-12-014034
Filing Date
2012-03-09
Accepted
2012-03-09 16:33:57
Documents
11
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v303134_10k.htm 10-K 898940
2 EXHIBIT 21.1 v303134_ex21-1.htm EX-21.1 2496
3 EXHIBIT 31.1 v303134_ex31-1.htm EX-31.1 9289
4 EXHIBIT 31.2 v303134_ex31-2.htm EX-31.2 9220
5 EXHIBIT 32.1 v303134_ex32-1.htm EX-32.1 5296
  Complete submission text file 0001144204-12-014034.txt   3201414

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nvlt-20111231.xml EX-101.INS 373794
7 XBRL TAXONOMY EXTENSION SCHEMA nvlt-20111231.xsd EX-101.SCH 18824
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvlt-20111231_cal.xml EX-101.CAL 41326
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvlt-20111231_def.xml EX-101.DEF 116938
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvlt-20111231_lab.xml EX-101.LAB 147597
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvlt-20111231_pre.xml EX-101.PRE 138920
Mailing Address ONE GATEWAY CENTER, SUITE 504 NEWTON MA 02458
Business Address ONE GATEWAY CENTER, SUITE 504 NEWTON MA 02458 617-244-1616
NOVELOS THERAPEUTICS, INC. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-119366 | Film No.: 12681047
SIC: 2834 Pharmaceutical Preparations